Akoya Biosciences, Inc.

We’re thrilled to introduce the Phenocycler-Fusion to our core lab – a cutting-edge platform designed to push the boundaries of spatial biology and single-cell analysis. 🔬 This innovative technology enables researchers to perform high-dimensional profiling on tissue samples, revolutionizing how we study disease mechanisms, biomarkers, and therapeutic responses. Feel free to reach out to our team for more information or to schedule a demo. We're excited to see the transformative impact this technology will have on your research! Kathleen Burns Namrata Singh, PhD Maria-Anna Chrysovergi Fieda Abderazzaq 🇵🇸 Jessie Cmaylo Dana-Farber Cancer Institute Harvard Medical School #SpatialBiology #SingleCellAnalysis #PhenocyclerFusion #CoreLab #ResearchInnovation #MultiOmic Akoya Biosciences, Inc. #ScientificDiscovery Read Details below: https://lnkd.in/dG3r2Wvv

Webinar Tomorrow - Defining Tumour Heterogeneity, One-Cell-at-a-Time Don’t forget to join us for this upcoming webinar where Arutha Kulasinghe will explore groundbreaking research on the tumor microenvironment (TME) in cancer patients. Focusing on immune checkpoint inhibitor responses in lung, head and neck, and skin cancers, we’ll dive into the biological mechanisms influencing patient outcomes. What you'll learn: Insights into the TME’s role in immunotherapy response How spatial-omics approaches are transforming cancer research Key differences between responders and non-responders at the cellular level Mark your calendars – you won’t want to miss this deep dive into cutting-edge cancer immunotherapy research! Date: Wednesday, 22nd January 2025 Time: 9AM PST | 12PM EST | 5PM GMT Register: LINKEDIN https://lnkd.in/g8c5vD4K

PhenoImager HT in action! Congratulations to all the authors involved.

We want to take a moment to express my sincere gratitude to everyone involved in making our recent Lunch & Learn a great success! A huge shoutout to Fieda Abderazzaq 🇵🇸 for organizing the event. Thank you to Kristen Legendre Doug Matthews from Akoya Biosciences, Inc. and Regan Baird from Visiopharm for their invaluable contributions. Your expertise and innovative solutions really helped elevate the session, and I’m sure everyone walked away with a wealth of new insights. 🌟 The event was a fantastic opportunity to connect, learn, and collaborate with like-minded professionals. Looking forward to future opportunities to engage and learn with such an amazing community. Thank you again to everyone involved! Kathleen Burns Namrata Singh, PhD Maria-Anna Chrysovergi Fieda Abderazzaq 🇵🇸 Jessie Cmaylo Dana-Farber Cancer Institute Harvard Medical School #Corelab #multiplexing #Immunoflorescence #SpatialBiology

🚀 Exciting News from Weizmann Institute of Science! 🚀 ❗ We’re thrilled to announce the installation of the first Akoya Biosciences, Inc. PhenoImager HT system in Israel at the Weizmann Institute of Science, Department of Veterinary Resources, led by Liat Fellus Alyagor, Head of the Immunohistochemistry Unit. The PhenoImager HT is a cutting-edge spectral slide scanning platform with unmatched imaging capabilities. It can unmix up to 9 fluorescent channels and add autofluorescence as a separate data channel! Additionally, HT can process up to 80 slides at once, offering exceptional throughput and precision. When paired with the Leica BOND RXm system, this combination creates a powerful platform for generating high volumes of data, providing deeper insights into both research and clinical applications. 📸 We’re especially excited to share an image captured in the lab of Prof. Itay Tirosh. This image was taken using the PhenoImager HT’s spectral scanning capabilities and shows PDX model of human PDAC tumors stained with mesenchymal and epithelial markers for tumor type phenotyping. “The Phenoimager HT significantly upgrades our work capacity, allows fast and easy multiplex imaging and together with the BOND RXm generates the perfect pipeline for OPAL multiplex staining.” – says Dr. Alyagor. This milestone marks a significant step forward in scientific discovery and biomedical research. We can’t wait to see the impact it will have! 🔬 Looking forward to the innovations and collaborations ahead! Salem Sirhan, M.Sc Rhenium Group

We will be at the upcoming annual J.P. Morgan Healthcare Conference in San Francisco, CA, from January 13–16, 2025! 🎉 Join us to discuss how Akoya is revolutionizing spatial proteomics and shaping the future of precision medicine. 📅 Connect with our team to learn more: Brian McKelligon, Johnny Ek, Pascal Bamford, Niro Ramachandran, Mark Landers, Priyam Shah, and Sambhav Dave Don’t hesitate to reach out to schedule a meeting or say hello! #Akoya #TheSpatialBiologyCompany #SpatialProteomics #JPM2025 #HealthcareInnovation #PrecisionMedicine

What it is: The Akoya Biosciences PhenoCycler-Fusion 1.0 instrument When it was acquired: October 2023 Where it is: Jimmy Fund Building, 2nd Floor What it does: This microscopic imaging system enables pathologists to see up to 100 molecular biomarkers across every cell in a tumor sample on a single slide, letting them visualize which molecules are in each cell and where they are across the entire tissue sample. This wealth of information reveals how the tissue is organized and provides a nuanced understanding to better diagnose and treat the disease. How it works: Research scientist Namrata Singh, PhD, uses the instrument's microfluidic system to apply a cocktail of up to 40 antibodies to a tissue sample slide. Each antibody binds to an antigen that is a unique portion of a biomarker of interest. She then uses the system to add antibody-specific fluorescent color-coded reporters, which glow with a distinct color to signal the presence of a particular biomarker. Using the system, these signals are revealed and imaged. The antibodies and reporters are then removed by the system in preparation for another cocktail. During imaging, the slide lights up with fluorescent colors, indicating the presence and location of the biomarkers. Singh can switch signals on and off, for instance, to focus on immune biomarkers or examine biomarkers that indicate a specific type, stage, or feature of the cancer. “When I first saw the Phenocycler images, I felt so emotional,” says Singh. “It’s just... I’m having goosebumps right now. You can clearly see not only the tumor but also the tumor microenvironment and how the disease is behaving.” What it is used for: Traditional methods for revealing biomarkers can only reveal two or three at a time. This system can show up to 100, which enables researchers to learn more about how cancer and its surrounding tissues interact with and respond to treatments. Special services for scientists: Singh uses the instrument to support researchers who want to learn more about tissue samples they've collected as part of a study. She can help researchers create custom antibodies to look at markers that have not been studied before. Fun fact: The substances used to create the slide stain cocktails are stored in what Singh calls her “deli fridge” because it looks like a fridge of sodas in a delicatessen.

🚨 𝐓𝐨𝐝𝐚𝐲 𝐢𝐬 𝐭𝐡𝐞 𝐋𝐀𝐒𝐓 𝐝𝐚𝐲 𝐭𝐨 𝐚𝐩𝐩𝐥𝐲!  🚨 Don’t miss your chance to take part in the 𝐈𝐎𝟔𝟎 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐆𝐫𝐚𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 and advance your research with cutting-edge 𝐬𝐩𝐚𝐭𝐢𝐚𝐥 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬 on the 𝐏𝐡𝐞𝐧𝐨𝐂𝐲𝐜𝐥𝐞𝐫®-𝐅𝐮𝐬𝐢𝐨𝐧 𝟐.𝟎 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦. Apply now to unlock a 60-marker spatial phenotyping dataset and collaborate with Akoya experts to push the boundaries of your genomics and transcriptomics studies. 👉 Apply Here: https://lnkd.in/eHJzupXd ⏳ Applications close TODAY, December 13, 2024!

Last week at #Multiomics2024 in Brisbane, we had the opportunity to re-unite with the researchers from the spatial community and hear from Niro Ramachandran on Akoya’s exciting new product launch including IO-60 panel and our clinical vision in the coming years. What a fantastic conference led by Arutha Kulasinghe! We even hosted a round-the-table discussion amongst our PhenoCycler-Fusion users from Australia to foster collaboration and strengthen the largest spatial proteomics community in the country. #spatialbiology #akoyabiosciences #geneworks #multiomics2024 #spatialproteomicscommunity

𝐓𝐡𝐞 𝐈𝐎𝟔𝟎 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐆𝐫𝐚𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 – 𝟐 𝐃𝐚𝐲𝐬 𝐋𝐞𝐟𝐭 𝐭𝐨 𝐀𝐩𝐩𝐥𝐲!  We’re thrilled to offer this game-changing opportunity to elevate your research with cutting-edge spatial proteomics on the PhenoCycler®-Fusion 2.0 platform. 💡 𝐖𝐡𝐚𝐭’𝐬 𝐢𝐧 𝐢𝐭 𝐟𝐨𝐫 𝐲𝐨𝐮?  ✅ A comprehensive 60-marker spatial phenotyping dataset tailored to your research. ✅ Expert guidance from Akoya’s spatial biology team to supercharge your genomics and transcriptomics studies. 𝐃𝐨𝐧’𝐭 𝐰𝐚𝐢𝐭—seize this moment to push the boundaries of your research! 📅 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝟏𝟑𝐭𝐡 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 Learn more and apply today! https://lnkd.in/eHJzupXd 𝐍𝐞𝐞𝐝 𝐈𝐧𝐬𝐩𝐢𝐫𝐚𝐭𝐢𝐨𝐧? Join our 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐞𝐫𝐢𝐞𝐬. Hear from leading experts in spatial biology as they share how they are integrating spatial technologies for a comprehensive, multi-analyte approach. https://lnkd.in/eZxpY2QC #SpatialProteomics #Genomics #Transcriptomics #ResearchGrant #AkoyaBiosciences